Commentary · 27 Feb 2025
Conference abstractPublished 26 Oct 2015
Necessary concepts in the design of the molecular structure and organic chemistry reactions for the synthesis of covalent biopharmaceuticals
Mississippi State University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Covalent bio-chemotherapeutics designed to possess properties of âÂ?Â?targetedâÂ? delivery have significant merit due to their capability to selectively promote progressive intracellular chemotherapeutic accumulation and impose minimal chemotherapeutic exposure to healthy tissues and organ systems. Chemotherapeutics most extensively employed in organic chemistry reactions schemes for synthesizing covalent immunochemotherapeutics or other bio-chemotherapeutics with similar characteristics have been the anthracyclines and to a lesser extent, bleomycin, calicheamicin, chlorambucil, dexamethasone, fludarabine, gemcitabine, methotrexate, maytansinoids, monomethyl auristatin E, paclitaxel and vinca alkaloids. A limited spectrum of organic chemistry reaction schemes have been utilized to covalently bond chemotherapeutics and other pharmaceuticals to synthetic macromolecules, immunoglobulin, receptor ligands, glycoproteins, polysaccharides and lectins that can facilitate selective âÂ?Â?targetedâÂ? delivery. Although methods have been described for synthesizing and purifying covalent bio-chemotherapeutics over prolonged reaction times, alternative methods and techniques have been developed that are efficient, rapid-in-duration, generate homogenous end-products with minimal side reactions and have modest requirements for advanced instrumentation. Critically important in the synthesis process of establishing the design of the molecular structure and organic chemistry reactions for synthesizing covalent immunochemotherapeutics is the selection of uniquely over-expressed sites on the external membrane of âÂ?Â?targetedâÂ? cell populations. Ideally these sites should each facilitate selective âÂ?Â?targetedâÂ? delivery, continual membrane deposition and progressive cytosol accumulation of a corresponding pharmaceutical moiety. Immunoglobulin as a carrier platform also affords the attribute of potentially promoting anti-neoplastic activity through both an anti-trophic effect and induction of multiple in vivo immune responses (e.g., antibody dependent cell cytotoxicity; complement cytolysis; opsonization).
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 3 Jul 2023
Organic Reactions and their Key Concepts in Organic Chemistry
Commentary · 30 Mar 2022
Chemistry of Covalently Bonded Carbon Compounds
Conference abstract
HPLC separation of enantiomers of some antifungals using covalently immobilized polysaccharide-based chiral selectors and polar organic mobile phases
Short communication · 8 Apr 2020
New organic chemistry of sulfur dioxide: new reactions, new reagents, total asymmetric synthesis of polypropionate antibiotics
More from this journal
The newest in Journal of Proteomics & Bioinformatics.
Perspective · 30 Dec 2025
Advances in Molecular Docking for Predicting Protein Ligand Interactions
Commentary · 30 Dec 2025
Machine Learning in Bioinformatics Transforming Biological Data into Predictive Insights
Perspective · 30 Dec 2025
Post-Translational Modifications as Dynamic Regulators of Proteome Complexity and Cellular Function
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Proteomics & Bioinformatics
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Cody P Coyne”

